Peptides vs. Anabolic Steroids: 7 Fundamental Differences [2026]
EXOMA Scientific Team · Publicado el · Actualizado el
Scientific comparison between peptides and anabolic steroids: mechanisms, legality in Mexico, side effects, reversibility, and applications. Everything you need to know.
Peptides and Steroids: Are They the Same?
No. Peptides and anabolic steroids are fundamentally different compounds in structure, mechanism of action, effect profile and legal status. This confusion is common but important to clarify.
Difference #1: Chemical Structure
Peptides
- Amino acid chains (2-50 amino acids joined by peptide bonds)
- Natural molecules — many peptides exist in the human body
- Examples: BPC-157 (15 amino acids), TB-500 (43 amino acids), GHK-Cu (3 amino acids)
Anabolic Steroids
- Derivatives of steroid hormones (structure of 4 carbon rings)
- Synthetic testosterone analogs
- Examples: Nandrolone, Oxandrolone, Trenbolone
Difference #2: Mechanism of Action
Peptides
- They act as signaling molecules — send messages to the cells
- Each peptide has a specific mechanism (regeneration, satiety, sleep, etc.)
- They do not directly alter hormone levels
- They activate the body's natural processes
Steroids
- They replace or supplement endogenous hormones
- Directly activate androgen receptors
- They alter the hormonal axis (HPT)
- They suppress natural testosterone production
Difference #3: Side Effects
| Effect | Peptides | Steroids |
|---|---|---|
| Supresión hormonal | No | Sí (significativa) |
| Daño hepático | No | Sí (orales 17-alfa-alquilados) |
| Acné severo | No | Frecuente |
| Calvicie acelerada | No | Sí (DHT-dependiente) |
| Gynecomastia | No | Sí (aromatización) |
| Water retention | Mínima | Significativa |
| Cambios de humor | No | Sí ("roid rage") |
| Virilización (mujeres) | No | Sí |
Peptides — Typical Side Effects
- Mild redness at the injection site
- Mild nausea (GLP-1 peptides)
- Drowsiness (DSIP)
- Appetite increase (GHRP-6)
Steroids — Documented Side Effects
- Suppression of the hypothalamic-pituitary-testicular axis
- Arterial hypertension
- Alteration of the lipid profile (cholesterol)
- Hepatic toxicity (oral compounds)
- Testicular atrophy
- Acne, baldness, voice changes
Difference #4: Reversibility
Peptides
- Effects are completely reversible upon ceasing administration
- They do not cause dependence
- They do not require post-cycle therapy (PCT)
- The body returns to its baseline state within days
Steroids
- Many effects are partially irreversible
- They require mandatory PCT (post-cycle therapy)
- Hormonal recovery can take months
- Some effects (baldness, voice in women) are permanent
Difference #5: Legality in Mexico
Research Peptides
- Legal for purchase and possession for research purposes
- Not classified as controlled substances in Mexico
- Available without prescription as research compounds (RUO)
- Regulated under research chemical regulations
Anabolic Steroids
- Controlled under the General Health Law of Mexico
- They require a prescription for therapeutic use
- Sale without a prescription is illegal
- Importation without authorization may result in seizure
Difference #6: Selectivity
Peptides
- Highly selective — each peptide has a specific function
- BPC-157 → tissue regeneration
- Retatrutida → receptores metabólicos GLP-1/GIP/Glucagón
- Epithalon → telomerase activity
- GHK-Cu → skin and hair regeneration
Steroids
- Broad systemic effect — they affect multiple tissues simultaneously
- You cannot "choose" where they act
- They affect the liver, prostate, skin, hair, hormonal axis indiscriminately
Difference #7: Research Applications
Peptides — Areas of Research
- Tissue regeneration (BPC-157, TB-500)
- Metabolism and body composition (Retatrutide, Tirzepatide)
- Neuroprotection (Semax, Selank, Cerebrolysin)
- Cellular longevity (Epithalon, NAD+)
- Salud dérmica (GHK-Cu, Matrixyl)
- Sleep and recovery (DSIP)
- Immunomodulation (Thymulin, LL-37)
Steroids — Medical Applications
- Hypogonadism (testosterone)
- Anemia (Nandrolone)
- Muscle wasting (Oxandrolone)
- Delayed puberty
Summary Table
| Criterio | Peptides | Steroids |
|---|---|---|
| Structure | Amino acids | Hormonas esteroideas |
| Mechanism | Cell signaling | Activación directa de receptores |
| Efectos secundarios | Mínimos, reversibles | Significativos, algunos permanentes |
| Legalidad México | Legal (research) | Controlados (requieren receta) |
| PCT necesaria | No | Sí (obligatorio) |
| Supresión hormonal | No | Sí |
| Selectividad | Alta (específicos) | Baja (sistémicos) |
| Toxicidad hepática | No | Sí (orales) |
Conclusion
Peptides and anabolic steroids are completely distinct categories of compounds. Peptides offer selectivity, reversibility and a superior safety profile for research. Steroids are potent medical tools but with significant risks that require supervision.
At EXOMA Peptides we offer exclusively research peptides with certified purity. We do not sell anabolic steroids.
See also
Literature on the compounds cited
- Sobre Cerebrolysine: Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial (Muresanu, et al. · Stroke · 2016) PMID 26564102.
- Sobre Cerebrolysine: A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease (Ruether, et al. · International Clinical Psychopharmacology · 2001) PMID 11552768.
- Sobre Cerebrolysine: Cerebrolysin in mild-to-moderate Alzheimer's disease: a meta-analysis of randomized controlled clinical trials (Gauthier, et al. · Dementia and Geriatric Cognitive Disorders · 2015) PMID 25832905.
- Sobre Tirzepatida: LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept (Coskun, et al. · Molecular Metabolism · 2018) PMID 30473097.
- Sobre Tirzepatida: Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial (Rosenstock, et al. · The Lancet · 2021) PMID 34186022.
- Sobre Tirzepatida: Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes (Thomas, et al. · Journal of Clinical Endocrinology & Metabolism · 2021) PMID 33236115.